In a new pilot feasibility study, researchers from Mayo Clinic, the University of Washington School of Medicine, the University of California San Francisco, and Nextrast Inc. found that a new imaging ...
New CT imaging oral contrast agent improves visualization of bowel anatomy, clinical trial data show
In a new pilot feasibility study, researchers from Mayo Clinic, the University of Washington School of Medicine, the University of California San Francisco, and Nextrast Inc. found that a new imaging ...
TOKYO--(BUSINESS WIRE)--Otsuka Pharmaceutical Co. Ltd. and its wholly-owned subsidiary Interpharma Praha, a.s. announced today that ORALTAG, a formulation of dry, dissolvable iohexol powder for oral ...
A new bismuth-based CT agent was synthesized through a facile synthesis strategy. The in vitro stability, toxicity and CT performance were evaluated. The in vivo imaging performance was investigated ...
Nanomedicine. 2015;10(2):321-341. Delivery: "Go where we want." The contrast agent must be able to be delivered in vivo and transported to the site of interest. Nontoxic: "Do no harm along the way." ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results